CIO
APRIL 17, 2024
The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations. A lot of this was incremental innovation around the user interface of coding assistants that developers have been using for 25 years,” says Sonnenblick.
CIO
OCTOBER 5, 2022
“Most people consider the CIO to be a technology person, and they want to put them in a technology box, but technology should be only 20% of a CIO’s job,” says Hadari, who has been leading IT for the $15 billion biotech business since March 2021. A CIO with a half billion-dollar budget is essentially the CEO of a very complex business.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
SEPTEMBER 18, 2023
Instead, a good portion of the IT organization embeds with scientists and other drug specialists to immerse in the various research initiatives, uncover the potential for IT innovation, and map the requisite technologies.
Netbasequid
FEBRUARY 22, 2021
In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9
Owler
MAY 17, 2023
Worldia’s product and the company’s resilience impressed investors like Credit Mutuel Innovation , who led the Series B funding round. Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds.
Sedulo
MARCH 15, 2023
Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)
Expert insights. Personalized for you.
793 
Let's personalize your content